Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?

Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?

Saved in:
Bibliographic Details
Published in:Journal francais d'ophtalmologie Vol. 43; no. 6; p. 548
Main Author: Defoort-Dhellemmes, S
Format: Journal Article
Language:French
Published: France 01-06-2020
Subjects:
Antimalarials - administration & dosage
Antimalarials - adverse effects
Betacoronavirus
Bone Density Conservation Agents - adverse effects
Contraindications, Drug
Coronavirus Infections - drug therapy
Coronavirus Infections - epidemiology
COVID-19
Humans
Hydroxychloroquine - administration & dosage
Hydroxychloroquine - adverse effects
Obesity - complications
Pandemics
Pneumonia, Viral - drug therapy
Pneumonia, Viral - epidemiology
Renal Insufficiency - complications
Retinal Diseases - chemically induced
Risk Factors
SARS-CoV-2
Tamoxifen - adverse effects
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1773-0597
DOI:10.1016/j.jfo.2020.04.014